AR
About
Education
Library
MEMBERSHIP
Business
Blog
login
Register Now
login
Register
Now
×
Log in
Remember me
Viewing 1180 results
Library Categories
ALL
Research & Ethics
Soft Skills
Medicine & Surgery
Pediatric
Internal Medicine
Neurology
ICU
General Surgery
ENT
Dermatology
Emergency
Family Medicine
OB & GYN
Psychiatry
General
Orthopedics
Radiology
Oncology
Diabetes
Rheumatology
Public Health
Allied Medical Sciences
MLT
Respiratory therapy
Physical therapy
Rehabilitation
Nursing
Pharmacy
Health Informatics
Health administration
Medical Education
Dentistry
E-Nutrition Hub
Dermatology
Ebglyss Monthly Maintenance Dosing.Simply No lab monitoring , No boxed warning & No dose adjustment
By :
Prof.Vimal Prajapati
Dermatology
Discover the 2 Years effcacy data of Ebglyss in Atopic Dermatitis – ADjoin Trial Highlights
By :
Prof.Vimal Prajapati
Dermatology
Ebglyss Clinical Trials: Proven Efficacy in Atopic Dermatitis – Advocate 1 and 2 Insights
By :
Prof.Vimal Prajapati
Dermatology
Ebglyss features a unique mechanism of action—binding to interleukin-13 with high affinity and a slow dissociation rate
By :
Prof.Vimal Prajapati
Oncology
Have You Heard? Jaypirca is Now Approved for R/R CLL!
By :
Dr.Tody Eyre
Dermatology
Unmet Medical Needs in Atopic Dermatitis: Ebglyss – A New IL-13 inhibitor Biologic for Moderate to Severe AD
By :
Prof.Vimal Prajapati
Dermatology
Empowering Atopic Dermatitis Management with Ebglyss Start Strong, Last Long, Maintain Monthly
By :
Prof.Vimal Prajapati
Dermatology
How Ebglyss (Lebrikizumab) Works in Atopic Dermatitis
By :
Lilly Saudi Arabia
Dermatology
Ebglyss Approved in Saudi Arabia – A New Hope for Moderate to Severe Atopic Dermatitis
By :
Lilly Saudi Arabia
Diabetes
SURMOUNT-5 Clinical Update–Now Published
By :
Carel W Le Roux
Diabetes
Bridging pathophysiology and epidemiology for better understanding of obesity
By :
Dr. Georgios K Dimitriadis
Health administration
مقدمة في إدارة الموارد البشرية في القطاع الصحي
By :
ا. حامد مرزا
Show More